Trials / Completed
CompletedNCT03294226
Comparison of AuraGain With I-gel for Pediatric Patients
A Randomized Trial of Ambu® AuraGain™ Versus I-gel® in Young Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 6 Months – 6 Years
- Healthy volunteers
- Not accepted
Summary
Children from 6 months to 6 years are randomly allocated into AuraGain group or I-gel group. After anesthetic induction without neuromuscular blocking agent, assigned device in inserted by skillful anesthesiologist. The outcome measures are recorded and analysed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AuraGain | After anesthetic induction without neuromuscular blocking agent, AuraGain is inserted. |
| DEVICE | I-gel | After anesthetic induction without neuromuscular blocking agent, I-gel is inserted. |
Timeline
- Start date
- 2017-09-25
- Primary completion
- 2018-03-23
- Completion
- 2018-03-24
- First posted
- 2017-09-26
- Last updated
- 2018-05-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03294226. Inclusion in this directory is not an endorsement.